Rockefeller Capital Management L.P. - INHIBIKASE THERAPEUTICS INC ownership

INHIBIKASE THERAPEUTICS INC's ticker is IKT and the CUSIP is 45719W106. A total of 27 filers reported holding INHIBIKASE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Rockefeller Capital Management L.P. ownership history of INHIBIKASE THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$2,000
-50.0%
1,5000.0%0.00%
Q2 2021$4,0001,5000.00%
Other shareholders
INHIBIKASE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Redmond Asset Management, LLC 125,805$62,9030.02%
Retirement Planning Co of New England, Inc. 35,212$17,6060.01%
CCG WEALTH MANAGEMENT, LLC 30,000$15,0000.01%
Koshinski Asset Management, Inc. 65,377$32,6880.00%
ZEKE CAPITAL ADVISORS, LLC 93,800$46,9000.00%
WELLS FARGO & COMPANY/MN 136$680.00%
NORTHERN TRUST CORP 28,872$14,4360.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 89,048$440.00%
STATE STREET CORP 121,000$60,5000.00%
View complete list of INHIBIKASE THERAPEUTICS INC shareholders